Comments*

 
  • Events 

    Monday, May 16, 2016 | 9:00 AM - 5:00 PM

    Exposing Vulnerabilities in Cancer Metabolism: New Discoveries

    Speakers: Kivanc Birsoy (The Rockefeller University), Steven S. Gross (Weill Cornell Medical College), Marcia Haigis (Harvard Medical School), Kayvan R. Keshari (Memorial Sloan Kettering Cancer Center), Brendan D. Manning (Harvard T.H. Chan School of Public Health), Joshua Rabinowitz (Princeton University), David M. Sabatini (Whitehead Institute), Reuben Shaw (Salk Institute for Biological Studies), and Eileen White (Rutgers University)

    This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.

    Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM

    Arrested Development: The Teenage Brain and Substance Abuse

    Moderator: Claudia Wallis (Scientific American Mind)
    Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), and Honorable Gregory P. Canova, JD; additional panelist to be announced

    1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.

    May 18 - 20, 2016

    The Addicted Brain and New Treatment Frontiers: Sixth Annual Aspen Brain Forum

    Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)

    Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.

    Monday, June 13, 2016 | 10:00 AM - 3:30 PM

    2016 Ross Prize in Molecular Medicine: Resolution of Inflammation

    Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.

    Tuesday, June 21, 2016 | 8:00 AM - 5:00 PM

    Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Keynote Speaker: Sharon Inouye (Harvard Medical School)

    This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.

  • Past Events

    Thursday, April 28, 2016 | 9:00 AM - 5:00 PM

    Epigenetics: Cancer and Beyond

    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
    Speakers: Michael Elowitz (California Institute of Technology), Eric Campeau (Zenith Epigenetics), Ewelina Kulikowski (Resverlogix Corp), Keiko Ozato (National Institute of Child Health and Human Development), Roberto Pili (Indiana University School of Medicine), Patrick Trojer (Constellation), Christopher Vakoc (Cold Spring Harbor Laboratory), Daniel Vitt (4SC AG)

    Epigenetic abnormalities are a recognized contributing factor in tumorigenesis and other diseases. This symposium describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetics marks.

    Tuesday, April 26, 2016 | 9:00 AM - 5:00 PM

    Solute Carrier Proteins: Unlocking the Gene-Family for Effective Therapies

    Speakers: Dax Fu (Johns Hopkins School of Medicine), Kathleen M. Giacomini (University of California, San Francisco), Matthias A. Hediger (University of Bern), Avner Schlessinger (Icahn School of Medicine at Mount Sinai), Giulio Superti-Furga (Austrian Academy of Sciences), Ming Zhou (Baylor College of Medicine), and Kim Huard (Pfizer Inc.)

    Solute Carrier Proteins are an untapped resource for drug discovery. This event will discuss breakthroughs in structural biology, cell engineering and metabolomics that hold the promise of "unlocking" this gene family.

    April 13 - 14, 2016

    Disease Drivers of Aging: 2016 Advances in Geroscience Summit

    Keynote Speakers: Richard Hodes (National Institute on Aging and National Institutes of Health), Felipe Sierra (National Institute on Aging and National Institutes of Health), Steven Austad (University of Alabama at Birmingham), and Elissa Epel (University of California, San Francisco)

    Explore how chronic diseases — specifically HIV/AIDS, diabetes, and cancer — can affect the seven mechanistic pillars of aging.

    March 30 - April 1, 2016

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Keynote Speakers: Richard Gilbertson (Cambridge Cancer Center, University of Cambridge), Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    Discover the latest on pediatric cancers from leading experts, including etiological differences between pediatric and adult cancers, epigenetics, mechanisms of metastasis and disease recurrence, risk factors, diagnostics, and novel treatment approaches.

  • Publications 

    eBriefing

    Regenerative Medicine: Transitioning Therapeutics from Cells to the Clinic

    Organizers: Jane S. Lebkowski (Asterias Biotherapeutics), George Zavoico (JonesTrading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    This eBriefing considers efforts to rethink clinical, regulatory, and manufacturing approaches to accelerate the transition of cell-based therapies to the clinic.

    eBriefing

    Clinical and Nutrition Interventions to Manage Disease-related Loss of Lean Body Mass

    Organizers: David Evans (Ohio State University), Refaat Hegazi (Abbott Nutrition Health Institute), Gerard Mullin (Johns Hopkins Medicine), Dennis H. Sullivan (University of Arkansas for the Medical Sciences), Kathy West (Abbott Nutrition Health Institute), Amy R. Beaudreault (The Sackler Institute for Nutrition Science), and Julie Shlisky (The Sackler Institute for Nutrition Science)

    This eBriefing reviews interventions for disease-related muscle mass loss.

    Annals

    Special Issue: Nutrition in Prevention and Management of Dementia

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue discusses emerging nutrition research on the prevention and management of dementia in aging populations.

    Volume 1367

    Annals

    Special Issue: The Year in Neurology and Psychiatry

    Edited by Daniel H. Geschwind (University of California, Los Angeles)

    Scholarly commissioned review articles on topics spanning neurology and psychiatry